← Research index  ·  Disorder page  ·  Source YAML

Cross-provider research synthesis

Spondyloepiphyseal Dysplasia Congenita

MONDO:0008471 Curated 2026-07-04T00:00:00Z 9 harmonized findings
falcon · 24 citations asta · 18 citations perplexity · 46 citations
Concordant asserts the finding Partial supports a weaker/qualified form Contradictory conflicts with it Silent does not address it

Harmonized findings

SEDC is an autosomal dominant type II collagenopathy caused by heterozygous pathogenic variants in COL2A1, the gene encoding the alpha-1(II) chain of type II collagen, the principal fibrillar collagen of hyaline cartilage.

UNANIMOUS INTEGRATED
genetic_factorpathophysiology
ProviderStanceScoreEvidence
falcon CONCORDANT 95% skeletal dysplasia within the **type II collagenopathy** spectrum caused by pathogenic variants in **COL2A1** (collagen type II alpha 1 chain)
Falcon states the COL2A1 causal gene and the type II collagenopathy framing directly, and elsewhere gives HGNC:2200 and the alpha-1(II) chain role.
DOI:10.1111/apa.70029, DOI:10.1016/j.bonr.2023.101728
asta CONCORDANT 92% Spondyloepiphyseal dysplasia congenita (SEDC) (OMIM#183900) is an autosomal dominant chondrodysplasia characterized by disproportionate short stature, abnormal epiphyses, flattened vertebral bodies (skeletal abnormalities), and extraskeletal features, including myopia, retinal degeneration with retinal detachment, and cleft palate. SEDC is caused by a heterozygous variant in the collagen II alpha 1 (COL2A1) gene.
A retrieved abstract (Akahira-Azuma 2022) names SEDC as an autosomal dominant COL2A1 chondrodysplasia caused by a heterozygous variant.
PMID:35581182
perplexity CONCORDANT 95% Spondyloepiphyseal dysplasia congenita (SEDC) is a rare autosomal dominant skeletal dysplasia with a prevalence of approximately 3.4 per million individuals that results from mutations in the COL2A1 gene encoding type II collagen
Perplexity states the autosomal dominant COL2A1 etiology in its opening summary.

The predominant SEDC mutation class is glycine substitution within the Gly-X-Y repeat of the triple-helical domain (roughly three-quarters of variants), which disrupts triple-helix assembly and acts through a dominant-negative mechanism.

UNANIMOUS INTEGRATED
genetic_factorgene_function
ProviderStanceScoreEvidence
falcon CONCORDANT 80% pathogenic COL2A1 variant (commonly glycine substitution in triple helix; or C-propeptide variant)
Falcon identifies glycine substitution in the triple helix as the common lesion but does not quantify the fraction or emphasize the dominant-negative statistics.
asta CONCORDANT 75% All five patients had novel missense variants resulting in glycine substitutions (G474V, G543E, G567S, G594R, and G1170R).
A retrieved SEDC cohort abstract reports glycine-substitution missense variants in every patient, supporting the predominant mutation class.
PMID:35581182
perplexity CONCORDANT 95% Approximately 74 percent of mutations result in glycine substitutions within the triple-helical domain, representing the most common pathogenic mechanism, while 10 percent involve arginine-to-cysteine (Arg-to-Cys) substitutions
Perplexity quantifies the glycine-substitution fraction (~74%) and separately details the dominant-negative versus haploinsufficiency mechanism dichotomy.

Misfolded mutant procollagen-II is retained and accumulates intracellularly in the (dilated) rough endoplasmic reticulum of chondrocytes, a central cellular defect that can trigger ER stress.

UNANIMOUS INTEGRATED
pathophysiology
ProviderStanceScoreEvidence
falcon CONCORDANT 90% ER retention/accumulation → ER dilation; variable engagement of canonical UPR transcription depending on context/dose.
Falcon places ER retention/accumulation and ER dilation at the core of the cellular defect, while flagging that downstream UPR engagement is context and dose dependent.
DOI:10.1101/2023.10.19.562780, DOI:10.1371/journal.pone.0086894
asta SILENT —
Asta is retrieval-only; its snippets touch ER stress only for other SED genes (MGP, MBTPS1), not the COL2A1 procollagen ER-retention mechanism, so it does not address this finding for SEDC.
perplexity CONCORDANT 92% The accumulation of misfolded mutant type II collagen within the ER lumen represents a potent trigger for cellular stress
Perplexity describes ER-lumen accumulation of misfolded collagen as a potent trigger of cellular stress activating the UPR sensors.

Sustained ER stress can drive growth-plate chondrocyte apoptosis and reduced chondrocyte proliferation, collapsing the hypertrophic zone and impairing endochondral ossification.

UNANIMOUS INTEGRATED
pathophysiology
ProviderStanceScoreEvidence
falcon CONCORDANT 85% chondrocyte apoptosis is a central causal event and occurs before hypertrophic differentiation, thereby collapsing the hypertrophic zone and impairing endochondral ossification
In the Col2a1 p.Gly1170Ser knock-in mouse, Falcon reports apoptosis preceding hypertrophy and collapsing the hypertrophic zone; it notes this is model dependent (absent in the iPSC model).
DOI:10.1371/journal.pone.0086894
asta SILENT —
Asta's retrieved snippets do not address chondrocyte apoptosis or growth-plate hypertrophic-zone collapse in SEDC.
perplexity CONCORDANT 90% elevated CHOP expression downstream of PERK activation has been documented to drive increased apoptosis through the intrinsic mitochondrial apoptosis pathway
Perplexity details the PERK/CHOP apoptotic program and, elsewhere, ER-stress reduction of growth-plate chondrocyte proliferation.

A recent human iPSC-derived cartilage model of COL2A1 p.Gly1170Ser reframes the ER-stress paradigm: it shows procollagen ER-storage without a coupled canonical UPR (and without increased apoptosis) in clinically relevant heterozygotes, challenging the universal "misfolding always leads to UPR and apoptosis" model.

CONFLICT LEAD
pathophysiology
ProviderStanceScoreEvidence
falcon CONCORDANT 90% In the 2024 iPSC cartilage model, despite prominent ER retention and ER dilation, transcriptome/GSEA analyses showed **no detectable UPR induction in clinically relevant heterozygotes**
Falcon foregrounds the Yammine iPSC finding of ER storage without a canonical UPR as a key recent nuance, explicitly calling UPR readouts unreliable proxies for collagen misfolding burden.
DOI:10.1101/2023.10.19.562780
asta SILENT —
Asta did not retrieve the Yammine iPSC preprint and does not address the storage-without-UPR nuance.
perplexity CONTRADICTORY 30% One of the central pathophysiological mechanisms underlying SEDC pathogenesis involves activation of the endoplasmic reticulum stress response and the unfolded protein response (UPR)
Perplexity presents canonical UPR activation as a central, established SEDC mechanism (largely from R992C mouse data) and does not acknowledge the iPSC-heterozygote finding of storage without UPR, directly at odds with the reframing Falcon highlights.

Mutant type II collagen is secreted at reduced rates and assembles into a defective extracellular matrix, with sparse, thinner, fewer and disorganized cartilage collagen fibrils.

UNANIMOUS INTEGRATED
pathophysiology
ProviderStanceScoreEvidence
falcon CONCORDANT 85% reduced cartilage type II collagen staining and EM evidence of fewer/less elaborate collagen fibrils plus enlarged ER vacuoles containing inclusions
Falcon cites the Esapa C-propeptide mouse showing fewer/less elaborate fibrils and reduced type II collagen, i.e., defective fibrillogenesis.
DOI:10.1002/jbmr.547
asta SILENT —
Asta's snippets address the genotype-phenotype spectrum but not the ultrastructural collagen-fibril / ECM assembly defect in SEDC cartilage.
perplexity CONCORDANT 90% Electron microscopic and biochemical analyses of SEDC mouse cartilage have revealed decreased fibril diameter compared to wild-type cartilage, coupled with increased amorphous material and reduced numbers of collagen fibrils overall
Perplexity reports decreased fibril diameter, increased amorphous material, and reduced fibril number, plus impaired lysyl-oxidase cross-linking.

SEDC presents with disproportionate short-trunk short stature, platyspondyly, and epiphyseal dysplasia, with frequent extraskeletal involvement (myopia, retinal detachment, sensorineural hearing loss, cleft palate).

UNANIMOUS INTEGRATED
phenotype
ProviderStanceScoreEvidence
falcon CONCORDANT 95% Disproportionate short stature / short trunk, platyspondyly, epiphyseal dysplasia, hip dysplasia/coxa vara, early osteoarthritis, myopia, retinal detachment, sensorineural hearing loss, cleft palate/Pierre Robin sequence.
Falcon lists the full skeletal plus extraskeletal phenotype set.
DOI:10.1038/s41439-022-00193-x, DOI:10.2147/tacg.s197205
asta CONCORDANT 85% disproportionate short stature, abnormal epiphyses, flattened vertebral bodies (skeletal abnormalities), and extraskeletal features, including myopia, retinal degeneration with retinal detachment, and cleft palate
A retrieved abstract enumerates the same skeletal and extraskeletal phenotype set.
PMID:35581182
perplexity CONCORDANT 90% characterized by disproportionate short stature with preferential shortening of the trunk, abnormal epiphyseal development, platyspondyly (flattened vertebral bodies), and multisystem involvement including significant ocular and auditory manifestations
Perplexity gives the same core phenotype and expands the ocular/auditory and cervical-spine complications in detail.

SEDC is a rare disorder with a reported prevalence of approximately 3.4 per million.

MAJORITY INTEGRATED
epidemiology
ProviderStanceScoreEvidence
falcon CONCORDANT 90% SEDC prevalence ~3.4 per 1,000,000
Falcon cites the Nenna COL2A1/SEDC review prevalence figure of ~3.4 per million.
DOI:10.2147/tacg.s197205
asta PARTIAL 40% the estimated incidence worldwide ranges from 20.4 to 35.9/100,000 across various locations and populations
Asta's retrieved figure is an incidence estimate for the broader type II collagenopathy spectrum, not the SEDC-specific ~3.4 per million point prevalence, so it overlaps in topic but reports a different measure and rate.
perplexity CONCORDANT 90% is a rare autosomal dominant skeletal dysplasia with a prevalence of approximately 3.4 per million individuals
Perplexity gives the same ~3.4 per million prevalence for SEDC.

SEDC sits within a genetically and phenotypically heterogeneous spondyloepiphyseal dysplasia spectrum; SEDC specifically is the COL2A1 (type II collagen) form, distinct from other SED entities caused by other genes (e.g., X-linked SEDL/TRAPPC2 tarda, TRPV4, MBTPS1, MGP).

MAJORITY LEAD
genetic_factordiagnosis
ProviderStanceScoreEvidence
asta CONCORDANT 70% SED with different clinical manifestations can be divided into spondyloepiphyseal dysplasia congenita (SEDC, OMIM# 183900), spondyloepiphyseal dysplasia-Kimberley type (SED-KT, OMIM# 608361), and spondyloepiphyseal dysplasia-Maroteaux type (SED-MT, OMIM# 184095).
Asta's retrieval leans heavily on the heterogeneous SED spectrum, surfacing distinct SED types and their differing causal genes (TRPV4, MBTPS1, MGP, SEDL/TRAPPC2) as a differential-diagnosis frame around COL2A1 SEDC.
PMID:36118854, PMID:15221797
perplexity PARTIAL 50% typically results from X-linked mutations in the TRAPPC2 gene
Perplexity notes the milder X-linked SEDT/TRAPPC2 form for contrast but keeps its focus tightly on COL2A1 SEDC, so it only partially engages the broader genetic heterogeneity of the SED spectrum.
falcon SILENT —
Falcon's report is confined to the COL2A1 mechanism and does not discuss the other genes or SED subtypes in the spondyloepiphyseal dysplasia spectrum.

Narrative

Overview

All three providers converge on the same disorder identity: SEDC is an autosomal dominant type II collagenopathy caused by heterozygous COL2A1 variants that disrupt the alpha-1(II) chain of hyaline-cartilage collagen. They differ sharply in method and depth. Falcon (Edison) is a focused pathophysiology synthesis built around the intracellular mechanism — misfolded procollagen-II, ER retention, and the ER-stress / UPR / apoptosis cascade — and it deliberately foregrounds a recent conceptual tension in that cascade. Perplexity (sonar-deep-research) is the most comprehensive: it walks the full arc from gene structure and mutation classes through cellular ER stress, growth-plate and endochondral-ossification failure, matrix biology, and the multisystem (skeletal, ocular, auditory, cervical-spine, respiratory) clinical course. Asta is retrieval-only — a ranked list of papers and snippets with no second-stage synthesis — so it frames SEDC mainly through the broader, genetically heterogeneous spondyloepiphyseal-dysplasia spectrum rather than through a single mechanistic narrative.

Agreement

The three reports agree strongly on the disease's genetic and clinical core. COL2A1 is the causal gene and inheritance is autosomal dominant (all three); glycine substitution within the Gly-X-Y triple-helical repeat is the predominant mutation class, which perplexity quantifies (~74%) and asta and falcon corroborate qualitatively. The clinical picture is consistent across providers: disproportionate short-trunk short stature, platyspondyly, and epiphyseal dysplasia, with frequent extraskeletal involvement (myopia, retinal detachment, sensorineural hearing loss, cleft palate). Falcon and perplexity additionally agree on the same rare-disease prevalence (~3.4 per million) and, at the mechanistic level, on ER retention of misfolded procollagen as the central cellular defect and on a defective, sparse, thin-fibril extracellular matrix.

Divergence

The genuine conflict is over ER-stress signaling. Falcon foregrounds the Yammine human iPSC-derived cartilage model of COL2A1 p.Gly1170Ser, which shows ER procollagen storage WITHOUT a coupled canonical UPR — and without increased apoptosis — in clinically relevant heterozygotes, and it explicitly argues that UPR readouts are not reliable proxies for collagen-misfolding burden. Perplexity, drawing largely on the R992C transgenic mouse, presents canonical UPR activation (IRE1a/PERK/ATF6, CHOP-driven apoptosis) as the central, established mechanism and does not acknowledge the storage-without-UPR result. These stances are recorded as CONTRADICTORY (falcon CONCORDANT vs. perplexity CONTRADICTORY on the reframing). Part of the tension is that the two lean on different model systems (iPSC heterozygote vs. mouse) and allele dosages. Beyond that conflict, divergence is mostly coverage: perplexity uniquely details the dominant-negative vs. haploinsufficiency dichotomy, the DDRGK1/UFMylation ER-homeostasis axis, and the late clinical course (early-onset osteoarthritis, ~40-year total hip arthroplasty, cervical myelopathy risk); falcon uniquely surfaces the iPSC "ER storage disorder" reframing; and asta uniquely maps the heterogeneous SED spectrum and its other causal genes (SEDL/TRAPPC2, TRPV4, MBTPS1, MGP) as a differential frame. Asta is otherwise SILENT on the intracellular mechanism, having not retrieved the mouse/iPSC mechanistic papers.

Integration

Promote the tri-provider consensus into the disorder YAML: the COL2A1 autosomal-dominant type II collagenopathy etiology, the predominant glycine-substitution / dominant-negative mutation mechanism, the misfolded-procollagen ER-retention cellular defect, the ER-stress-linked chondrocyte apoptosis and growth-plate / endochondral-ossification failure (as a MODEL_ORGANISM-supported node, given its mouse basis), the defective sparse-fibril cartilage ECM, the short-trunk/platyspondyly/epiphyseal plus extraskeletal phenotype set, and the ~3.4 per million prevalence. These are well corroborated and ready for evidence-backed curation once the underlying PMIDs/DOIs are fetch-verified.

Not integrated (leads)

Retain as leads rather than promoting outright: (1) the model-dependent UPR question — whether clinically relevant heterozygous SEDC involves canonical UPR activation (mouse) or ER storage without a coupled UPR (human iPSC) — is an unresolved human-model-fidelity tension best captured as a knowledge-gap / HUMAN_MODEL_MISMATCH lead rather than asserted as settled mechanism; and (2) perplexity's DDRGK1/UFMylation-stabilized IRE1a axis and its implied therapeutic angle, which is a single-provider mechanistic lead not yet corroborated here. Both should await primary-literature verification before entering the disorder YAML.

Three provider reports compared: falcon (Edison, pathophysiology-focused, ER stress / UPR emphasis), asta (retrieval-only paper+snippet listing, broad SED spectrum), and perplexity (sonar-deep-research, comprehensive COL2A1 review). Strong tri-provider agreement on the COL2A1 autosomal-dominant etiology, glycine-substitution mutation class, core short-trunk/platyspondyly/epiphyseal plus extraskeletal phenotype, and (falcon/perplexity) the ~3.4 per million prevalence. The one genuine conflict is on ER-stress signaling: falcon foregrounds the Yammine human iPSC finding of ER procollagen storage WITHOUT a coupled canonical UPR in clinically relevant heterozygotes, whereas perplexity presents canonical UPR activation (largely R992C mouse data) as the central mechanism — recorded as a CONTRADICTORY stance and a LEAD pending curation. Asta is SILENT on the intracellular ER-stress / apoptosis / fibrillogenesis mechanism (retrieval did not surface the mouse/iPSC mechanistic papers) but contributes a distinctive SED-spectrum genetic-heterogeneity/differential frame. best_matching_text values are verbatim excerpts from the cited report files; the perplexity DDRGK1/UFMylation ER-homeostasis lead was noted but not carried as a separate harmonized finding. Literature evidence snippets are intentionally left for the disorder-YAML curation pipeline.